Literature DB >> 7499829

Differential expression of alternate mB7-2 transcripts.

F Borriello1, J Oliveros, G J Freeman, L M Nadler, A H Sharpe.   

Abstract

The murine B7-2 (mB7-2) costimulatory molecule is expressed on APCs early during the course of an immune response, suggesting that it may play a pivotal role in the decision between T cell activation and anergy. Murine B7-2 mRNA displays a restricted pattern of expression; it is inducible in B cells, T cells, NK cells, and dendritic cells, but constitutively expressed in unstimulated monocytes. The constitutive and inducible expression of mB7-2 on distinct cell types indicates that mB7-2 is regulated differentially. To further characterize mB7-2 transcripts, we employed 5' rapid amplification of cDNA ends and reverse transcriptase-PCR to examine transcripts expressed in a variety of types of APCs and analyzed the genomic organization of the mB7-2 gene. We report here that the mB7-2 locus consists of 12 exons and demonstrate that exons 1 through 5 can be used in alternative fashions to produce five distinct transcripts, differing in their 5' untranslated and signal regions. The expression of these transcripts differs in distinct types of APCs and is modulated by stimuli that activate B cells. These results demonstrate that mB7-2 transcripts are differentially regulated in a tissue-specific fashion and in response to activation stimuli.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499829

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Characterization and localization of Mox2, the gene encoding the murine homolog of the rat MRC OX-2 membrane glycoprotein.

Authors:  F Borriello; R Tizard; E Rue; R Reeves
Journal:  Mamm Genome       Date:  1998-02       Impact factor: 2.957

2.  Structural organization and mammary-specific expression of the butyrophilin gene.

Authors:  S L Ogg; M V Komaragiri; I H Mather
Journal:  Mamm Genome       Date:  1996-12       Impact factor: 2.957

Review 3.  Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy.

Authors:  Bita Amir Taghavi; Nazila Alizadeh; Hossein Saeedi; Noora Karim Ahangar; Afshin Derakhshani; Khalil Hajiasgharzadeh; Nicola Silvestris; Behzad Baradaran; Oronzo Brunetti
Journal:  Molecules       Date:  2022-05-31       Impact factor: 4.927

4.  B7-2 expressed on EL4 lymphoma suppresses antitumor immunity by an interleukin 4-dependent mechanism.

Authors:  C Stremmel; E A Greenfield; E Howard; G J Freeman; V K Kuchroo
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

Review 5.  The B7 family of immune-regulatory ligands.

Authors:  Mary Collins; Vincent Ling; Beatriz M Carreno
Journal:  Genome Biol       Date:  2005-05-31       Impact factor: 13.583

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.